|
LINCS: A linear constraint solver for molecular simulations
|
journal
|
September 1997 |
|
Overview of Current Methods in Sedimentation Velocity and Sedimentation Equilibrium Analytical Ultracentrifugation
|
journal
|
February 2013 |
|
GROMACS: Fast, flexible, and free
|
journal
|
January 2005 |
|
Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models
|
journal
|
October 1992 |
|
Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic Data
|
journal
|
March 2020 |
|
Editorial: Proteins of SARS CoV-2, the Cause of COVID-19, and the Proteins that Interact with Them
|
journal
|
December 2020 |
|
Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode
|
journal
|
January 2010 |
|
Activation and maturation of SARS-CoV main protease
|
journal
|
April 2011 |
|
SARS-CoV-2 Resistance to Small Molecule Inhibitors
|
journal
|
June 2024 |
|
On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation
|
journal
|
September 2003 |
|
Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling
|
journal
|
March 2000 |
|
Analytical Ultracentrifugation: Sedimentation Velocity and Sedimentation Equilibrium
|
book
|
January 2008 |
|
Calculations and Publication-Quality Illustrations for Analytical Ultracentrifugation Data
|
book
|
January 2015 |
|
Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2
|
journal
|
May 2023 |
|
The SARS-CoV-2 main protease as drug target
|
journal
|
September 2020 |
|
Viral precursor polyproteins: keys of regulation from replication to maturation
|
journal
|
April 2013 |
|
Exploration of P1 and P4 modifications of nirmatrelvir: Design, synthesis, biological evaluation, and X-ray structural studies of SARS-CoV-2 Mpro inhibitors
|
journal
|
March 2024 |
|
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease
|
journal
|
March 2023 |
|
Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors
|
journal
|
July 2023 |
|
Characterization of alternate encounter assemblies of SARS-CoV-2 main protease
|
journal
|
September 2024 |
|
Production of Authentic SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein Overproduction
|
journal
|
February 2007 |
|
Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor
|
journal
|
December 2022 |
|
Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
|
journal
|
December 2020 |
|
Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing
|
journal
|
December 2021 |
|
Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure
|
journal
|
June 2009 |
|
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies
|
journal
|
December 2021 |
|
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease
|
journal
|
October 2021 |
|
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
|
journal
|
March 2022 |
|
Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir
|
journal
|
June 2022 |
|
Effects of SARS-CoV-2 Main Protease Mutations at Positions L50, E166, and L167 Rendering Resistance to Covalent and Noncovalent Inhibitors
|
journal
|
October 2024 |
|
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
|
journal
|
May 2020 |
|
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
|
journal
|
August 2021 |
|
P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation
|
journal
|
December 2007 |
|
Resistance mechanisms of SARS-CoV-2 3CLpro to the non-covalent inhibitor WU-04
|
journal
|
April 2024 |
|
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
|
journal
|
June 2020 |
|
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
|
journal
|
April 2022 |
|
A new coronavirus associated with human respiratory disease in China
|
journal
|
February 2020 |
|
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir
|
journal
|
September 2023 |
|
Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor
|
journal
|
March 2022 |
|
Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain
|
journal
|
September 2022 |
|
Insights into the mechanism of SARS-CoV-2 main protease autocatalytic maturation from model precursors
|
journal
|
November 2023 |
|
Rapid resistance profiling of SARS-CoV-2 protease inhibitors
|
journal
|
August 2023 |
|
Polymorphic transitions in single crystals: A new molecular dynamics method
|
journal
|
December 1981 |
|
Particle mesh Ewald: An N ⋅log( N ) method for Ewald sums in large systems
|
journal
|
June 1993 |
|
A smooth particle mesh Ewald method
|
journal
|
November 1995 |
|
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
|
journal
|
October 2016 |
|
Unusual zwitterionic catalytic site of SARS–CoV-2 main protease revealed by neutron crystallography
|
journal
|
October 2020 |
|
Mutation of Gly-11 on the Dimer Interface Results in the Complete Crystallographic Dimer Dissociation of Severe Acute Respiratory Syndrome Coronavirus 3C-like Protease
|
journal
|
January 2008 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
electronic Ligand Builder and Optimization Workbench ( eLBOW ): a tool for ligand coordinate and restraint generation
|
journal
|
September 2009 |
|
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Overview of the CCP 4 suite and current developments
|
journal
|
March 2011 |
|
How good are my data and what is the resolution?
|
journal
|
June 2013 |
|
Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography
|
journal
|
October 2021 |
|
The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro)
|
journal
|
August 2022 |
|
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
|
journal
|
October 2019 |
|
Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CL pro ) from its polyproteins
|
journal
|
March 2013 |
|
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
|
journal
|
March 2023 |
|
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
|
journal
|
March 2020 |
|
Mechanism for Controlling the Dimer-Monomer Switch and Coupling Dimerization to Catalysis of the Severe Acute Respiratory Syndrome Coronavirus 3C-Like Protease
|
journal
|
February 2008 |
|
Evaluation of in vitro antiviral activity of SARS-CoV-2 M pro inhibitor pomotrelvir and cross-resistance to nirmatrelvir resistance substitutions
|
journal
|
November 2023 |
|
Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M pro /3CL pro in Living Cells
|
journal
|
June 2022 |
|
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
|
journal
|
February 2020 |